Substrate specificity of vaccinia virus thymidylate kinase

FEBS Journal

Volumn 272, Issue 24, 2005, Pages 6254-6265

  Topalis, Dimitri ^a   Collinet, Bruno ^a   Gasse, Cécile ^b   Dugué, Laurence ^b   Balzarini, Jan ^c   Pochet, Sylvie ^b   Deville Bonne, Dominique ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

5 lododeoxyuridine; Antiviral nucleoside; MABA derivative; Poxvirus; Thymidylate kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE MAGNESIUM; GUANOSINE PHOSPHATE; HOMODIMER; IDOXURIDINE; NUCLEOSIDE MONOPHOSPHATE KINASE; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; THYMIDINE PHOSPHATE; THYMIDYLATE KINASE; UNCLASSIFIED DRUG; URIDINE PHOSPHATE; VIRUS ENZYME;

ARTICLE; BINDING AFFINITY; BINDING SITE; CATALYSIS; CONTROLLED STUDY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ESCHERICHIA COLI; MOLECULAR CLONING; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN TARGETING; SEQUENCE HOMOLOGY; VACCINIA VIRUS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CLONING, MOLECULAR; DEOXYRIBONUCLEOTIDES; ENZYME INHIBITORS; KINETICS; NUCLEOSIDE-PHOSPHATE KINASE; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY; VACCINIA VIRUS; VIRUS REPLICATION;

ESCHERICHIA COLI; ORTHOPOXVIRUS; POXVIRIDAE; VACCINIA VIRUS;

EID: 29144473268     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.05006.x     Document Type: Article

References (42)

1. Bray M & Buller M (2004) Looking back at smallpox. Clin Infectious Dis 38, 882-889.
2. De Clercq E (1997) Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology 40, 295-303.
3. Quenelle D, Collins D & Kern E (2003) Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice. Antimicrob Agents Chemother 47, 3275-3280.
4. Magee WC, Hostetler KY & Evans DH (2005) Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicrob Agents Chemother 49, 3152-3162.
5. Smee DF, Sidwell RW, Kefauver D, Bray M & Huggins JW (2002) Characterisation of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox and vaccinia viruses. Antimicrob Agents Chemother 46, 1329-1335.
6. Moss B (1990) Poxviridae and their replication. Virology (Fields BN, Knipe DM, Chanock FM, Airsch MS, Melnick JL, Monath TR & Roizman B, eds), pp. 2079-2111. Raven Press, Ltd, New York.
7. Smith GL, De Carlos A & Chan YS (1989) Vaccinia virus encodes a thymidilate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res 17, 7581-7590.
8. Hughes SJ, Johnston LH, De Carlos A & Smith GL (1991) Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem 30, 20103-20109.
9. Lavie A, Ostermann N, Brundiers R, Goody RS, Reinstein J, Konrad M & Schlichting I (1998) Structural basis for efficient phosphorylation of 3′-azido-thymidine monophosphate by Escherichia coli thymidylate kinase. Proc Natl Acad Sci USA 95, 14045-14050.
10. Ostermann N, Schlichting I, Brundiers R, Konrad M, Reinstein J, Veit T, Goody RS & Lavie A (2000) Insights into the phosphoryltransfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate. Structure 8, 629-642.
11. Li de la Sierra I, Munier-Lehmann H, Gilles AM, Barzu O & Delarue M (2001) X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 Å resolution. J Mol Biol 311, 87-100.
12. Fyfe JA, Keller PM, Furman P, Miller R & Elion GB (1978) Thymidine kinase from Herpes Simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl) guanine. J Biol Chem 253, 8721-8727.
13. Naesens L & De Clerq E (2001) Recent development in Herpesvirus therapy. Herpes 8, 12-16.
14. Coen DM & Schaffer PA (2003) Antiherpesvirus drugs: a promising spectrum of new drugs and drugs targets. Nature Rev 2, 278-288.
15. Munier-Lehmann H, Chaffotte A, Pochet S & Labesse G (2001) Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes. Protein Sci 10, 1195-1205.
16. Pochet S, Dugué L, Labesse G, Delepierre M & Munier-Lehmann H (2003) Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and humans. Chembiochem 4, 742-747.
17. Haouz A, Vanheusden V, Munier-Lehmann H, Froeyen M, Herdewijn P, van Calenbergh S & Delarue M (2003) Enzymatic and structural analysis of inhibitors designed against Mycobacterium tuberculosis thymidylate kinase. J Biol Chem 278, 4963-4971.
18. Chenal-Francisque V, Tourneux L, Carniel E, Christova P, Li de la Sierra I, Barzu O & Gilles AM (1999) The highly similar TMP kinases of Yersinia pestis and Escherichia coli differ markedly in their AZTMP phosphorylating activity. Eur J Biochem 265, 112-119.
19. Petit CM & Koretke KK (2002) Characterization of Streptococcus pneumoniae thymidylate kinase: steady-state kinetics of the forward reaction and isothermal titration calorimetry. Biochem J 363, 825-831.
20. Balzarini J, Herdewijn P & De Clercq E (1989) Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′, 3′-dideoxy-thymidine (d4T) and 3′-azido-2′,3′-dideoxy- thymidine (AZT), two potent anti-HIV compounds. J Biol Chem 264, 6127-6133.
21. Lee LS & Cheng YC (1977) Human thymidylate kinase: purification, characterization, and kinetic behavior of the thymidylate kinase derived from chronic myelocytic leukemia. J Biol Chem 252, 5686-5691.
22. Jong AYS & Campbell JL (1984) Characterization of Saccharomyces cerevisiae thymidylate kinase, the cdc8 gene product. J Biol Chem 259, 14394-14398.
23. Ostermann N, Segura-Pena D, Meier C, Veit T, Monnerjahn C, Konrad M & Lavie A (2003) Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds. Biochemistry 42, 2568-2577.
24. Hiratsuka T (1984) Affinity labeling of the myosin ATPase with ribose-modified fluorescent nucleotides and vanadate. J Biochem (Tokyo) 96, 147-154.
25. Rudolph MG, Veit TJH & Reinstein J (1999) The novel fluorescent CDP-analogue (Pβ) MABA-CDP is a specific probe for the NMP binding site of UMP-CMP kinase. Protein Sci 8, 2697-2704.
26. Bone R, Cheng YC & Wolfenden R (1986) Inhibition of adenosine and thymidylate kinases by bisubstrates analogs. J Biol Chem 261, 16410-16413.
27. Bucurenci N, Sakamoto H, Briozzo P, Palibroda N, Serina L, Sarfati RZ, Labesse G, Briand G, Danchin A, Bârzu O & Gilles AM (1996) CMP kinase from Escherichia coli is structurally related to other nucleoside monophosphate kinases. J Biol Chem 271, 2856-2862.
28. Wurth C, Thomas RM, Folkers G & Scapozza L (2001) Folding and self-assembly of Herpes Simplex virus type 1 thymidine kinase. J Mol Biol 313, 657-670.
29. Hu R, Li L, Degrève B, Dutschman GE, Lam W & Cheng YC (2005) Behaviour of thymidylate kinase toward monophosphate metabolites and its role in the metabolism of L-FMAU (Clevudine) and d4T in cells. Antimicrob Agents Chemother 49, 2044-2049.
30. Brundiers R, Lavie A, Veit T, Reinstein J, Schlichting I, Ostermann N, Goody RS & Konrad M (1999) Modifying human thymidylate kinase to potentiate azidothymidine activation. J Biol Chem 274, 35289-35292.
31. Pasti C, Gallois-Montbrun S, Munier-Lehmann H, Véron M, Gilles AM & Deville-Bonne D (2003) Reaction of human UMP-CMP kinase with natural and analog substrates. Eur J Biochem 270, 1-7.
32. Ayabe T, Park SK, Takenaka H, Takenaka O, Maruyama H, Sumida M, Onitsuka T & Hamada M (2000) The steady-state kinetics of the enzyme reaction tested by site-directed mutagenesis of hydrophobic residues (Val, Leu and Cys) in the C-terminal a-helix of human adenylate kinase. J Biochem 128, 181-187.
33. Balzarini J, Liekens S, Esnouf R & De Clercq E (2002) The A167Y mutation converts the Herpes Simplex virus type 1 thymidine kinase into a guanosine analogue kinase. Biochemistry 41, 6517-6524.
34. Knecht W, Sandrini MPB, Johansson K, Eklund H, Munch-Petersen B & Piskur J (2002) A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines. EMBO J 21, 1873-1880.
35. Teplyakov A, Sebastiao P, Obmolova G, Perrakis A, Brush GS, Bessman MJ & Wilson KS (1996) Crystal structure of bacteriophage T4 deoxynucleotide kinase with its substrates dGMP and ATP. EMBO J 15, 3486-3497.
36. Ross LS, Landman O & Little JG (1987) Base analogue mutagenesis in yeast and its modulation by pyrimidine deoxynucleotide pool imbalances: incorporation of bromodeoxyuridylate and iododeoxyuridylate. Curr Genet 11, 421-427.
37. Neyts J, Verbeken E & De Clercq E (2002) Effect of 5-iodo-2′-deoxyuridine on vaccinia virus (Orthopoxvirus) infections in mice. Antimicrob Agents Chemother 46, 2842-2847.
38. Butterfield K & Thomas EJ (1998) Synthesis of analogues of nucleotides with all-carbon backbones: synthesis of N-protected C-linked dinucleotides. J Chem Soc Perkin Trans I 1, 737-744.
39. Gill SC & Von Hippel PH (1989) Calculation of protein extinction coefficient from amino acid sequence data. Anal Biochem 182, 319-326.
40. Blondin C, Serina L, Wiesmuller L, Gilles AM & Bârzu O (1994) Improved spectrophotometric assay of nucleoside monophopshate kinase activity using the pyruvate kinase/lactate dehydrogenase coupling system. Anal Biochem 220, 219-221.
41. Swillens S (1995) Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis. Mol Pharmacol 47, 1197-1203.
42. Chen Y, Gallois-Montbrun S, Schneider B, Veron M, Morera S, Deville-Bonne D & Janin J (2003) Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases. J Mol Biol 332, 914-926.